Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Michelle A Albert, MD, MPH

    SchoolUCSF School of Medicine
    vCardDownload vCard

      Collapse Biography 
      Collapse Awards and Honors
      Induction to 2016 Class2016Elected Member, Association of University Cardiologists
      Haverford College2015The Haverford Award, recognizing an alumnus who uses their knowledge to the benefit of society
      Circulation Journal (June 17, 2014)2014Featured "Editor's Choice & Scientist": MA Health Care Reform, Race/Ethnicity and CVD
      Women's Day Magazine2014Red Dress Award Honoree
      American College of Cardiology2012Second Annual Heart of Women's Health CREDO Award
      Brigham and Women’s Hospital, Boston MA2010Nesson Fellowship Award
      Brigham and Women's Hospital, Boston MA2006J Ira and Nikki Harris Family Research Award
      Brigham and Women’s Hospital, Boston MA2003Learner Young Investigator Award,
      Association of Black Cardiologists, Inc2004Herbert W. Nickens Epidemiology Award
      Brigham and Women’s Hospital, Boston MA2001Brigham and Women's Hospital/Kraft Minority Faculty Development Award

      Collapse Overview 
      Collapse Overview
      Dr. Michelle A. Albert is a general cardiologist with expertise in preventive cardiovascular medicine as well as managing the most critically ill cardiovascular patients with a range of conditions including coronary artery disease, valvular heart disease, cardiomyopathies and vulnerable populations with heart disease such as women and racial/ethnic minorities. Dr. Albert brings extensive clinical experience from her previous roles as core cardiovascular faculty for over a decade at Brigham and Women’s Hospital, Boston MA and Associate Professor at Harvard Medical School. Recently, she served as Vivian Allen Beaumont Endowed Professor and Chief of Cardiovascular Medicine at Howard University, Washington DC. Albert received her undergraduate degree in Chemistry from Haverford College and medical degree from the University of Rochester. She trained in internal medicine at Columbia University, New York, where she served as chief medical resident and instructor in Medicine. Dr. Albert then completed her cardiovascular clinical and research fellowships at Brigham and Women’s Hospital and Harvard Medical School, as well as a Masters in Public Health degree with concentrations in Epidemiology and Clinical Effectiveness at Harvard School of Public Health. Additionally, she has completed a one year Brigham Executive Leadership Program at Harvard Business School.

      Dr. Albert is the Director of the Center for the Study of Adversity and Cardiovascular Disease at UCSF Cardiology. This new translational center is focused on the overarching theme of "the biology of adversity", a non-traditional area in cardiovascular research where data are sparse. Dr. Albert’s research requires highly collaborative networks and seeks to understand and develop novel solutions related to poor educational, quality of life and cardiovascular health outcomes across the lifespan. Research themes of specific interest include chronic psychological stress, neurocardiology, longevity, cardiovascular risk biomarkers and cardiovascular health outcomes related to vulnerable populations utilizing national datasets. Dr. Albert is Principal Investigator on a 5 year RO1 grant entitled, "Cumulative Stress and Cardiovascular Disease in Middle-Aged and Older Women" from the NIH/NIA. She is Co-Principal Investigator along with Dr. David Williams at Harvard School of Public Health, on a grant from the Kellogg Foundation about the adversity and health.

      Collapse ORNG Applications 
      Collapse In The News
      Collapse Awarded Grants
      Collapse Global Health

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Hira RS, Bhatt DL, Fonarow GC, Heidenreich PA, Ju C, Virani SS, Bozkurt B, Petersen LA, Hernandez AF, Schwamm LH, Eapen ZJ, Albert MA, Liang L, Matsouaka RA, Peterson ED, Jneid H. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry. J Am Heart Assoc. 2016 Oct 6; 5(10). PMID: 27792640.
        View in: PubMed
      2. Cozier YC, Albert MA, Castro-Webb N, Coogan PF, Ridker P, Kaufman HW, Palmer JR, Rosenberg L. Neighborhood Socioeconomic Status in Relation to Serum Biomarkers in the Black Women's Health Study. J Urban Health. 2016 Apr; 93(2):279-91. PMID: 27000125.
        View in: PubMed
      3. Slopen N, Chen Y, Priest N, Albert MA, Williams DR. Emotional and instrumental support during childhood and biological dysregulation in midlife. Prev Med. 2016 Mar; 84:90-6. PMID: 26708307.
        View in: PubMed
      4. Slopen N, Shonkoff JP, Albert MA, Yoshikawa H, Jacobs A, Stoltz R, Williams DR. Racial Disparities in Child Adversity in the U.S.: Interactions With Family Immigration History and Income. Am J Prev Med. 2016 Jan; 50(1):47-56. PMID: 26342634.
        View in: PubMed
      5. Slopen N, Non A, Williams DR, Roberts AL, Albert MA. Childhood adversity, adult neighborhood context, and cumulative biological risk for chronic diseases in adulthood. Psychosom Med. 2014 Sep; 76(7):481-9. PMID: 25077427; PMCID: PMC4353633.
      6. Albert MA, Ayanian JZ, Silbaugh TS, Lovett A, Resnic F, Jacobs A, Normand SL. Early results of Massachusetts healthcare reform on racial, ethnic, and socioeconomic disparities in cardiovascular care. Circulation. 2014 Jun 17; 129(24):2528-38. PMID: 24727094.
        View in: PubMed
      7. Redmond N, Richman J, Gamboa CM, Albert MA, Sims M, Durant RW, Glasser SP, Safford MM. Perceived stress is associated with incident coronary heart disease and all-cause mortality in low- but not high-income participants in the Reasons for Geographic And Racial Differences in Stroke study. J Am Heart Assoc. 2013 Dec; 2(6):e000447. PMID: 24356528; PMCID: PMC3886761.
      8. Albert MA. Not there yet: Medicare Part D and elimination of cardiovascular medication usage sociodemographic disparities after myocardial infarction. Circulation. 2014 Feb 18; 129(7):723-4. PMID: 24326989.
        View in: PubMed
      9. Slopen N, Kontos EZ, Ryff CD, Ayanian JZ, Albert MA, Williams DR. Psychosocial stress and cigarette smoking persistence, cessation, and relapse over 9-10 years: a prospective study of middle-aged adults in the United States. Cancer Causes Control. 2013 Oct; 24(10):1849-63. PMID: 23860953; PMCID: PMC3776130.
      10. Plitt A, Dorbala S, Albert MA, Giugliano RP. Cardiac sarcoidosis: case report, workup, and review of the literature. Cardiol Ther. 2013 Dec; 2(2):181-97. PMID: 25135396; PMCID: PMC4107425.
      11. Clark CR, Ommerborn MJ, Hickson DA, Grooms KN, Sims M, Taylor HA, Albert MA. Neighborhood disadvantage, neighborhood safety and cardiometabolic risk factors in African Americans: biosocial associations in the Jackson Heart study. PLoS One. 2013; 8(5):e63254. PMID: 23691005; PMCID: PMC3653956.
      12. Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation. 2013 Mar 19; 127(11):1254-63, e1-29. PMID: 23429926; PMCID: PMC3684065.
      13. Powell-Wiley TM, Ayers CR, de Lemos JA, Lakoski SG, Vega GL, Grundy S, Das SR, Banks-Richard K, Albert MA. Relationship between perceptions about neighborhood environment and prevalent obesity: data from the Dallas Heart Study. Obesity (Silver Spring). 2013 Jan; 21(1):E14-21. PMID: 23404728; PMCID: PMC3602329.
      14. Slopen N, Glynn RJ, Buring JE, Lewis TT, Williams DR, Albert MA. Job strain, job insecurity, and incident cardiovascular disease in the Women's Health Study: results from a 10-year prospective study. PLoS One. 2012; 7(7):e40512. PMID: 22815754; PMCID: PMC3399852.
      15. Tsenkova VK, Albert MA, Georgiades A, Ryff CD. Trait anxiety and glucose metabolism in people without diabetes: vulnerabilities among black women. Diabet Med. 2012 Jun; 29(6):803-6. PMID: 22587407; PMCID: PMC3395206.
      16. Slopen N, Dutra LM, Williams DR, Mujahid MS, Lewis TT, Bennett GG, Ryff CD, Albert MA. Psychosocial stressors and cigarette smoking among African American adults in midlife. Nicotine Tob Res. 2012 Oct; 14(10):1161-9. PMID: 22367977; PMCID: PMC3457711.
      17. Lee TC, Glynn RJ, Peña JM, Paynter NP, Conen D, Ridker PM, Pradhan AD, Buring JE, Albert MA. Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study. PLoS One. 2011; 6(12):e27670. PMID: 22194788; PMCID: PMC3237410.
      18. Albert MA. Biomarkers and heart disease. J Clin Sleep Med. 2011 Oct 15; 7(5 Suppl):S9-11. PMID: 22003335; PMCID: PMC3190417.
      19. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J, Zhang SM, Buring JE. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012 Jan; 33(1):159-71. PMID: 21986389; PMCID: PMC3253961.
      20. Albert MA, Glynn RJ, Fonseca FA, Lorenzatti AJ, Ferdinand KC, MacFadyen JG, Ridker PM. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. Am Heart J. 2011 Jul; 162(1):106-14.e2. PMID: 21742096.
        View in: PubMed
      21. Albert MA, Williams DR. Invited commentary: Discrimination--an emerging target for reducing risk of cardiovascular disease? Am J Epidemiol. 2011 Jun 1; 173(11):1240-3. PMID: 21354989.
        View in: PubMed
      22. Powell TM, de Lemos JA, Banks K, Ayers CR, Rohatgi A, Khera A, McGuire DK, Berry JD, Albert MA, Vega GL, Grundy SM, Das SR. Body size misperception: a novel determinant in the obesity epidemic. Arch Intern Med. 2010 Oct 11; 170(18):1695-7. PMID: 20937931.
        View in: PubMed
      23. Moukarbel GV, Albert MA. The ecology of stent thrombosis: a view from a sociobiological perspective. Circulation. 2010 Sep 14; 122(11):1053-5. PMID: 20805426.
        View in: PubMed
      24. Albert MA. Receipt of high-quality coronary heart disease care in the United States: all about being black or white: comment on "Racial differences in admissions to high-quality hospitals for coronary heart disease". Arch Intern Med. 2010 Jul 26; 170(14):1216-7. PMID: 20660839.
        View in: PubMed
      25. Slopen N, Lewis TT, Gruenewald TL, Mujahid MS, Ryff CD, Albert MA, Williams DR. Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey. Psychosom Med. 2010 Sep; 72(7):694-701. PMID: 20595419; PMCID: PMC2939196.
      26. Albert MA, Cozier Y, Ridker PM, Palmer JR, Glynn RJ, Rose L, Halevy N, Rosenberg L. Perceptions of race/ethnic discrimination in relation to mortality among Black women: results from the Black Women's Health Study. Arch Intern Med. 2010 May 24; 170(10):896-904. PMID: 20498418; PMCID: PMC3020569.
      27. Cook NR, Albert MA. Regarding REGARDS: Does inflammation explain racial and regional differences in cardiovascular disease risk? Clin Chem. 2009 Sep; 55(9):1603-5. PMID: 19589843.
        View in: PubMed
      28. Albert MA, Pare G, Morris A, Rose L, Buring J, Ridker PM, Zee RY. Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: data from the Women's Genome Health Study. Am Heart J. 2009 Apr; 157(4):777-83.e1. PMID: 19332210; PMCID: PMC2737822.
      29. Conen D, Glynn RJ, Ridker PM, Buring JE, Albert MA. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J. 2009 Jun; 30(11):1378-84. PMID: 19297384; PMCID: PMC2721710.
      30. Albert MA. Heart failure in the urban African enclave of Soweto: a case study of contemporary epidemiological transition in the developing world. Circulation. 2008 Dec 2; 118(23):2323-5. PMID: 19047590.
        View in: PubMed
      31. Albert MA, Ravenell J, Glynn RJ, Khera A, Halevy N, de Lemos JA. Cardiovascular risk indicators and perceived race/ethnic discrimination in the Dallas Heart Study. Am Heart J. 2008 Dec; 156(6):1103-9. PMID: 19033005.
        View in: PubMed
      32. Albert MA. Race/ethnicity and inflammation: is there a link to periodontal disease? J Periodontol. 2008 Jul; 79(7):1121-3. PMID: 18597591.
        View in: PubMed
      33. Albert MA. Inflammatory biomarkers, race/ethnicity and cardiovascular disease. Nutr Rev. 2007 Dec; 65(12 Pt 2):S234-8. PMID: 18240555.
        View in: PubMed
      34. Albert MA, Glynn RJ, Buring JE, Ridker PM. Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: a prospective analysis of the Women's Health Study. Atherosclerosis. 2008 Mar; 197(1):297-302. PMID: 17640650; PMCID: PMC2947154.
      35. Albert MA, Glynn RJ, Buring JE, Ridker PM. Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. Am J Cardiol. 2007 May 1; 99(9):1246-51. PMID: 17478152; PMCID: PMC1939813.
      36. Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation. 2006 Dec 12; 114(24):2619-26. PMID: 17116764.
        View in: PubMed
      37. Albert MA, Ridker PM. C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation. 2006 Aug 1; 114(5):e67-74. PMID: 16880331.
        View in: PubMed
      38. Albert MA, Glynn RJ, Wolfert RL, Ridker PM. The effect of statin therapy on lipoprotein associated phospholipase A2 levels. Atherosclerosis. 2005 Sep; 182(1):193-8. PMID: 15982658.
        View in: PubMed
      39. Unic D, Mihaljevic T, Leacche M, Gasparovic H, Albert MA, Byrne JG. Surgical treatment of a large left-main coronary artery aneurysm. Thorac Cardiovasc Surg. 2004 Aug; 52(4):230-1. PMID: 15293160.
        View in: PubMed
      40. Albert MA, Torres J, Glynn RJ, Ridker PM. Perspective on selected issues in cardiovascular disease research with a focus on black Americans. Circulation. 2004 Jul 13; 110(2):e7-12. PMID: 15249517.
        View in: PubMed
      41. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004 May 15; 93(10):1238-42. PMID: 15135696.
        View in: PubMed
      42. Albert MA, Glynn RJ, Ridker PM. Effect of physical activity on serum C-reactive protein. Am J Cardiol. 2004 Jan 15; 93(2):221-5. PMID: 14715354.
        View in: PubMed
      43. Albert MA, Ridker PM. Inflammatory biomarkers in African Americans: a potential link to accelerated atherosclerosis. Rev Cardiovasc Med. 2004; 5 Suppl 3:S22-7. PMID: 15303082.
        View in: PubMed
      44. Blake GJ, Albert MA, Rifai N, Ridker PM. Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial. Eur Heart J. 2003 Oct; 24(20):1843-7. PMID: 14563343.
        View in: PubMed
      45. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003 Jul 15; 108(2):161-5. PMID: 12835213.
        View in: PubMed
      46. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 2003 Jan 28; 107(3):443-7. PMID: 12551869.
        View in: PubMed
      47. Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001 Jul 4; 286(1):64-70. PMID: 11434828.
        View in: PubMed
      48. Albert MA, Staggers J, Chew P, Ridker PM. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design. Am Heart J. 2001 Jun; 141(6):893-8. PMID: 11376301.
        View in: PubMed
      49. Albert MA, Rifai N, Ridker PM. Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis. Vasc Med. 2001; 6(3):145-9. PMID: 11789968.
        View in: PubMed
      50. Albert MA. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep. 2000 Jul; 2(4):274-9. PMID: 10953259.
        View in: PubMed
      51. Albert MA, Ridker PM. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep. 1999 Jul; 1(2):99-104. PMID: 10980827.
        View in: PubMed
      Michelle A's Networks
      Related Concepts
      Derived automatically from this person's publications.
      Related Authors
      People who share related concepts with this person.
      Back to TOP